Your browser doesn't support javascript.
loading
TAK-228 (formerly MLN0128), an investigational dual TORC1/2 inhibitor plus paclitaxel, with/without trastuzumab, in patients with advanced solid malignancies.
Burris, Howard A; Kurkjian, C D; Hart, L; Pant, S; Murphy, P B; Jones, S F; Neuwirth, R; Patel, C G; Zohren, F; Infante, J R.
Afiliação
  • Burris HA; Sarah Cannon Research Institute, 250 25th Avenue North, #100, Nashville, TN, 37203, USA. Howard.Burris@scresearch.net.
  • Kurkjian CD; Tennessee Oncology PLLC, Nashville, TN, USA. Howard.Burris@scresearch.net.
  • Hart L; Sarah Cannon Research Institute, 250 25th Avenue North, #100, Nashville, TN, 37203, USA.
  • Pant S; Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
  • Murphy PB; Sarah Cannon Research Institute, 250 25th Avenue North, #100, Nashville, TN, 37203, USA.
  • Jones SF; Florida Cancer Specialists, Fort Myers, FL, USA.
  • Neuwirth R; Sarah Cannon Research Institute, 250 25th Avenue North, #100, Nashville, TN, 37203, USA.
  • Patel CG; Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
  • Zohren F; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Infante JR; Sarah Cannon Research Institute, 250 25th Avenue North, #100, Nashville, TN, 37203, USA.
Cancer Chemother Pharmacol ; 80(2): 261-273, 2017 Aug.
Article em En | MEDLINE | ID: mdl-28601972

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirimidinas / Benzoxazóis / Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Chemother Pharmacol Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirimidinas / Benzoxazóis / Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Chemother Pharmacol Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos